Navigation Links
inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007
Date:2/28/2008

Company's financial statements more directly comparable on a period-to-period basis. The Company's objectives in presenting non-GAAP financial measures are:

-- To present the financial statements on a more comparable period-to-

period basis;

-- To enhance investors' overall understanding of the Company's past

financial performance and its planning and forecasting of future

periods; and

-- To allow investors to assess the Company's financial performance using

management's analytical approach.

Table 3 below contains reconciliations of the non-GAAP financial measures contained in this press release to the most directly comparable GAAP financial measures.

The "adjusted" non-GAAP financial measures discussed in this press release is related to the following five factors:

-- Receivable reserve: During the second quarter of 2007, the Company

recorded additional reserves for receivables and other related expense

of $8.2 million ($4.8 million net of taxes), of which $0.1 million

(negligible, net of taxes) was reversed during the fourth quarter of

2007, mainly relating to a collections issue due to the bankruptcy of

one of its clients within the Commercial segment. Historical write-

offs have been minimal and the Company does not believe there is a

significant risk that the circumstances giving rise to these additional

reserves will recur in future periods. The 2007 full year results were

adjusted to exclude the recording and reversals of these receivable

reserves.

-- Other than Temporary Impairment on Marketable Securities: During the

fourth quarter of 2007, the Company recorded $0.8 million ($0.5 million

net of taxes) related to an other than temporary impairment of the

Company's Columbia Strategic Cash Portfolio ("CSCP"), which held

certain asset-bac
'/>"/>

SOURCE inVentiv Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. inVentiv Health Ranked #17 by Training Magazine in its 2008 List of Top 125 Training Companies
2. inVentiv Health to Announce Fourth Quarter and Full Year 2007 Results and Conduct Conference Call on Thursday, February 28th
3. inVentiv Health Provides Updated Information on December 11th Investor Day
4. inVentiv Health Creates Client Development and Integration Team
5. inVentiv Health to Present at the 2007 Credit Suisse Healthcare Conference
6. inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes
7. inVentiv Health to Announce Third Quarter Results and Conduct Conference Call on Wednesday, November 7, 2007
8. inVentiv Health to Present at the 20th Annual Bear Stearns Healthcare Conference
9. Crdentia Selected by Leading Staffing Vendor to Provide Health Care Staffing Services to One of the Largest Hospital Chains in the U.S.
10. Former Blue Cross/Blue Shield Account Manager Sentenced for Health Care Fraud Scheme, Tax Evasion
11. UCLA launches network to study health care disparities affecting minorities

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... , , WASHINGTON, Dec. 4 /PRNewswire-USNe...h care overhaul plan, Family Research Council (FRC...ll household phones in Louisiana to survey each ho...ll. These include abortion funding, rationing, hi... public option. Survey participants who express o...
(Date:12/4/2009)... , , PACIFIC PALISADES, Calif., Dec. 4 /P...ason and give your loved ones something they can b...ith Dermagenics® Physician-Formulated Anti-Wr...timate youthful appearance made possible with an a...ed. ,, Dermagenics Ultra-Intensive Anti-Wrinkle...
(Date:12/4/2009)... Social network profile usually conveys true pers...(HealthDay News) -- Does your profile on an online... you? The odds are good that it does, reports a ne...heir true selves instead of idealized identities. ... widely held assumption is that people are using t...
(Date:12/4/2009)... , , BATESVILLE, Ind., Dec. 4 /PRNewswire...C ) today announced its fiscal 2010 first quarter ...eclared by Hill-Rom,s Board of Directors on Decemb...o shareholders of record as of December 17, 2009. ...ill-Rom is a leading worldwide manufacturer and pr...
(Date:12/4/2009)... , , UNION, N.J., Dec. 4 /PRNewswire/ -...xpanded its specialty anatomic pathology services ...offering. The new service completes the company,s ...national anatomic pathology company offering diagn...including gastroenterology, urology and now hemato...
Breaking Medicine News(10 mins):Health News:FRC Announces Campaign to Call Every Louisiana Household, Urging Opposition to Health Care Takeover 2Health News:Give the Gift of Beautiful Skin for the Holiday Season 2Health News:Online Identities Likely to Match Reality 2Health News:PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services 2Health News:PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services 3
...es PDL,s Queen et al. Patents for Soliris(R) , ,...5 PDL BioPharma, Inc. (Nasdaq: PDLI ) and Alex... jointly announced that the companies have entered...oliris(R) (eculizumab) and PDL,s patents known as ...
... Jan. 5 The Ensign Group, Inc. (Nasdaq: ENSG ),...althcare Center, a 150-bed skilled nursing facilit...uary 1, 2009. The facility has been renamed Southl...ition, and adds to our growing critical mass in th...
...O, Calif., Jan. 5 The Ensign Group, Inc. (Nasdaq:...brillo Care Center, a 156-bed skilled nursing faci...was effective January 1, 2009. The facility has be...o extend our growing footprint into California,s C...
... LFC Group of Companies Announces Newest... Colorado , Newport Beach...real estate auction marketing firm, LFC Group of C...E.com/284R3 ). The auction, a builder closeout of ...
... Help us, help the Red Cross meet the wi...n our new Hyundai Dealer showroom at 271 Main St. ...ou,re one of the first 50 to donate blood. , ...he recent ice & snow storms that hit New Engla...
... A proven and widely adopted research in...milestone this fall with the implementation at a w.... At the end of September, the University of Wisco...n needs. OnCore is the flagship product of PercipE...
Other Medicine News:Health News:Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute 2Health News:Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute 3Health News:The Ensign Group Acquires Texas Skilled Nursing Facility 2Health News:The Ensign Group Acquires California Skilled Nursing Facility 2Health News:Let the Bidding Begin in Online Auction of Denver Luxury Homes 2Health News:Let the Bidding Begin in Online Auction of Denver Luxury Homes 3Health News:Let the Bidding Begin in Online Auction of Denver Luxury Homes 4Health News:Boston Hyundai Dealer Teams up With the Red Cross to Save Lives 2Health News:OnCore System Supporting Research Informatics Needs of the University of Wisconsin's Institute for Clinical and Translational Research 2Health News:OnCore System Supporting Research Informatics Needs of the University of Wisconsin's Institute for Clinical and Translational Research 3Health News:OnCore System Supporting Research Informatics Needs of the University of Wisconsin's Institute for Clinical and Translational Research 4
(Date:12/4/2009)... ,, WASHINGTON, Dec. 4 /PRNewswire-US...d a new report published by the Pharmaceutical ...hat identifies 97 new drugs and vaccines in develo..., The report found that the 97 products in devel...e drugs are either in human clinical trials or awa...
(Date:12/4/2009)... , BILLERICA, Mass., Dec. 4 /PRNewswire-First...subsidiary of Volcano Corporation (Nasdaq: VOLC )...essful testing of a novel integrated light source ... proprietary optical engine design raises the bar ...ions of laser-based designs for swept source OCT l...
(Date:12/4/2009)..., BETHESDA, Md., Dec. 4 ...ompany") (OTC Bulletin Board: NWBO) announced toda...wed its patent application on a system for automat...e Company,s DCVax® therapeutic cancer vaccine...the very high concentration of dendritic cells (wh...
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Press Ganey Announces Opening of Boston Office 50837 1Press Ganey Announces Opening of Boston Office 50837 2Economy Forces Most Wired Hospitals to Look Closely at IT Spending 50835 1Economy Forces Most Wired Hospitals to Look Closely at IT Spending 50835 2Economy Forces Most Wired Hospitals to Look Closely at IT Spending 50835 3Pitt team first to profile genes in acutely ill idiopathic pulmonary fibrosis patients 9127 1Pitt team first to profile genes in acutely ill idiopathic pulmonary fibrosis patients 9127 2Pitt team first to profile genes in acutely ill idiopathic pulmonary fibrosis patients 9127 3
...cs, Inc. (OTC Bulletin Board: CVBT) has entered in...e the sponsor and general,partner of ProDerm Limit...,$1 million and up to $10 million of the clinical ...e., "I am extremely impressed with CVBT,s wound h...treat patients for diabetic ulcers and venous,stas...
...on Study Demonstrates an Improvement in De..., Calif., May 22 CNS Response, Inc.,(OTC Bulletin...y presented,at the American Psychiatric Associatio...tt, M.D., Chief Medical Officer, Walden Behavioral...grams. The poster presentation,titled "Referenced-...
Other Medicine Technology:Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial 2Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial 3CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 2CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 3CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 4CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 5CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 6
...imaging and an extraordinary combination of featur...pecialty clinical environment. The versatility and...are allows you to perform a wide variety of exams ...eal choice for multiple imaging modalities, the SS...
Anti HTLV -I/HTLV -II
...currently developing additional assays for the blo...3.47 million to date in contract funding from the ...as been used to develop the Procleix WNV Assay. Th...centers under an Investigational New Drug Applicat...
Anti-HBc: CORE Test
Medicine Products: